Differential distribution of blood and lymphatic vessels in the murine cornea

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 5, 2010, Pages 2436-2440

  Ecoiffier, Tatiana ^a   Yuen, Don ^a   Chen, Lu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; CORNEA LIMBUS; KERATITIS; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CORNEA; CORNEA NEOVASCULARIZATION; DISEASE MODEL; FLUORESCENCE MICROSCOPY; METABOLISM; VASCULARIZATION;

CD31 ANTIGEN; GLYCOPROTEIN; XLKD1 PROTEIN, MOUSE;

ANIMALS; ANTIGENS, CD31; BLOOD VESSELS; CORNEA; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; KERATITIS; LIMBUS CORNEAE; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE;

EID: 77952530963     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4505     Document Type: Article

References (28)

1. Brown P. Lymphatic system: unlocking the drains. Nature. 2005; 436:456-458.
2. Jackson DG. Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis. APMIS. 2004;112:526-538.
3. Chang L, Kaipainen A, Folkman J. Lymphangiogenesis new mechanisms. Ann N Y Acad Sci. 2002;979:111-119.
4. Oliver G, Detmar M. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 2002;16:773-783.
5. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946-953.
6. Chen L. Ocular lymphatics: state-of-the-art review. Lymphology. 2009;42:66-76.
7. Chong EM, Dana MR. Graft failure, IV: immunologic mechanisms of corneal transplant rejection. Int Ophthalmol. 2008;28:209-222.
8. Cursiefen C, Chen L, Dana MR, Streilein JW. Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea. 2003;22:273-281.
9. Van Buskirk EM. The anatomy of the limbus. Eye. 1989;3:101-108.
10. Meyer PA. The circulation of the human limbus. Eye. 1989;3:121-127.
11. Hill JC. The relative importance of risk factors used to define high-risk keratoplasty. Ger J Ophthalmol. 1996;5:36-41.
12. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci. 2001;42:1293-1298.
13. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med. 2004;10:813-815.
14. Chen L, Huq S, Gardner H, de Fougerolles AR, Barabino S, Dana MR. Very late antigen 1 blockade markedly promotes survival of corneal allografts. Arch Ophthalmol. 2007;125:783-788.
15. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45:2666-2673.
16. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113: 1040-1050.
17. Chen L, Cursiefen C, Barabino S, Zhang Q, Dana MR. Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells. Invest Ophthalmol Vis Sci. 2005;46:4536-4540.
18. Bock F, Onderka J, Hos D, Horn F, Martus P, Cursiefen C. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp Eye Res. 2008; 87:462-470.
19. Dastjerdi MH, Al-Arfaj KM, Nallasamy N, et al. Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol. 2009;127:381-389.
20. Cogan DG. Development and senescence of the human retinal vasculature. Trans Ophthalmol Soc U K. 1963;83:465-489.
21. Patz A. The role of oxygen in retrolental fibroplasia. Sinai Hosp J (Balt). 1957;6:3-22.
22. Weinberg DV, Egan KM, Seddon JM. Asymmetric distribution of arteriovenous crossings in the normal retina. Ophthalmology. 1993;100:31-36.
23. Sakimoto T, Shoji J, Inada N, Saito K, Iwasaki Y, Sawa M. Histological study of conjunctiva-associated lymphoid tissue in mouse. Jpn J Ophthalmol. 2002;46:364-369.
24. Steven P, Rupp J, Huttmann G, et al. Experimental induction and three-dimensional two-photon imaging of conjunctiva-associated lymphoid tissue. Invest Ophthalmol Vis Sci. 2008;49:1512-1517.
25. Chang LK, Garcia-Cardena G, Farnebo F, et al. Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci U S A. 2004;101:11658-11663.
26. Cursiefen C, Maruyama K, Jackson DG, Streilein JW, Kruse FE. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea. 2006;25:443-447.
27. Rogers MS, Birsner AE, D'Amato RJ. The mouse cornea micropocket angiogenesis assay. Nat Protoc. 2007;2:2545-2550.
28. Dua HS, Shanmuganathan VA, Powell-Richards AO, Tighe PJ, Joseph A. Limbal epithelial crypts: a novel anatomical structure and a putative limbal stem cell niche. Br J Ophthalmol. 2005;89:529-532.